Brook Itzhak, Gober Alan E
Department of Pediatrics, Georgetown University, Schools of Medicine, Washington, DC, USA.
Acta Paediatr. 2008 Feb;97(2):193-5. doi: 10.1111/j.1651-2227.2007.00610.x.
The presence of beta-lactamase-producing bacteria is associated with the failure of penicillins to eradicate Group A beta-hemolytic streptococci in patients with pharyngo-tonsillitis. This study correlated the rate of recovery of beta-lactamase-producing bacteria from healthy children with the rate of amoxicillin failure to eradicate Group A streptococci from children with acute Group A streptococcal pharyngo-tonsillitis.
A total of 228 children with Group A streptococcal pharyngo-tonsillitis, treated with amoxicillin for 10 days, and 663 healthy children were evaluated in a single year. Pharyngo-tonsillar cultures were obtained from all well children and from those with pharyngo-tonsillitis before treatment and on the 12th day.
Amoxicillin failed to eradicate Group A streptococci from 48 of the 228 treated children (21%). Amoxicillin failure rate varied from month to month; it was high between October and May (22-32%), with the exception of April (11%); and low between June and September (8% to 12%). Beta-lactamase-producing bacteria were recovered from 226 of 663 (34%) well children. The rate of recovery of beta-lactamase-producing bacteria varied; it was also high between October and May (40-52%), with exception of April (23%), and the lowest between June and September (10-12%). Prior to their treatment, beta-lactamase-producing bacteria were recovered from 26 of the 48 (54%) children who eventually failed amoxicillin therapy, and from 28 of the 180 (16%) who did not fail (p < 0.001).
A correlation was noted between the rate of recovery of beta-lactamase-producing bacteria in healthy children and the rate of amoxicillin failure to eradicate Group A streptococci. A high failure rate of penicillins in eradication of Group A streptococci in pharyngo-tonsillitis can serve as sensitive indicator for a high prevalence rate of beta-lactamase-producing bacteria in the community.
产β-内酰胺酶细菌的存在与青霉素类药物无法根除咽扁桃体炎患者中的A组β溶血性链球菌有关。本研究将健康儿童中产β-内酰胺酶细菌的检出率与阿莫西林未能根除急性A组链球菌性咽扁桃体炎患儿中A组链球菌的失败率进行了关联分析。
在同一年对总共228例接受阿莫西林治疗10天的A组链球菌性咽扁桃体炎患儿以及663例健康儿童进行了评估。在治疗前和第12天从所有健康儿童以及患有咽扁桃体炎的儿童中采集咽扁桃体培养物。
在228例接受治疗的患儿中,有48例(21%)阿莫西林未能根除A组链球菌。阿莫西林的失败率随月份而变化;10月至次年5月间失败率较高(22% - 32%),4月除外(11%);6月至9月间失败率较低(8% - 12%)。在663例(34%)健康儿童中检出了产β-内酰胺酶细菌。产β-内酰胺酶细菌的检出率也有所不同;同样在10月至次年5月间较高(40% - 52%),4月除外(23%),6月至9月间最低(10% - 12%)。在最终阿莫西林治疗失败的48例患儿中有26例(54%)在治疗前检出了产β-内酰胺酶细菌,而在治疗未失败的180例患儿中有28例(16%)检出(p < 0.001)。
注意到健康儿童中产β-内酰胺酶细菌的检出率与阿莫西林未能根除A组链球菌的失败率之间存在关联。青霉素类药物在根除咽扁桃体炎中A组链球菌时的高失败率可作为社区中产β-内酰胺酶细菌高流行率的敏感指标。